Enzymofit announced that it will receive NIS 1.4 million in equity round of funding on February 22, 2024. The transaction included the participation from new investors EnzymoCore for NIS 1.05 million and hold 75% stake in the company and Feat Fund Investments - Limited Partnership for NIS 350,000 and hold 25% stake in the company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
116 ILa | 0.00% | 0.00% | -24.58% |
- Stock Market
- Equities
- FEAT Stock
- News Feat Fund Investments - Limited Partnership
- Enzymofit announced that it expects to receive ILS 1.4 million in funding from EnzymoCore, Feat Fund Investments - Limited Partnership